Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 146

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 146
---
 resale under this prospectus is dependent upon the number of shares of Common Stock, if any, we ultimately sell to Keystone under the Keystone Purchase Agreements. Further, if and when we elect to sell shares of Common Stock to Keystone pursuant to the Keystone Purchase Agreements, after Keystone has acquired such shares, Keystone may resell all, some or none of such shares of Common Stock at any time or from time to time in its discretion and at different prices. The issuance of our shares of Common Stock to the Selling Securityholder pursuant to the Purchase Agreements will not affect the rights or privileges of our existing stockholders, except that the economic and voting interests of each of our existing stockholders will be diluted. Although the number of shares of Common Stock that our existing stockholders own will not decrease, the shares of Common Stock owned by our existing stockholders will represent a smaller percentage of our total outstanding shares of Common Stock after any such issuance. 78 Although the Keystone Purchase Agreements provides that we may sell up to an aggregate of $25.0 million of our shares of our Common Stock to Keystone, we have only registered an aggregate of 12,616,818 shares of Common Stock for resale under the Registration Statements, including 12,500,000 Keystone Purchase Shares pursuant to the registration statement of which this prospectus forms a part. If it becomes necessary for us to issue and sell more shares than are being registered for resale under the Registration Statements in order to receive aggregate gross proceeds equal to $25.0 million under the Keystone Purchase Agreements, we must first file with the SEC one or more additional registration statements to register under the Securities Act the resale by Keystone of any such additional shares of our Common Stock we wish to sell from time to time under the Keystone Purchase Agreements, which the SEC must declare effective, in each case, before we may elect to sell any additional shares of our Common Stock to Keystone under the Keystone Purchase Agreements. The following table sets forth the number of Keystone Purchase Shares to be issued to Keystone under the New Keystone Purchase Agreement registered hereunder at varying purchase prices:

| Assumed Purchase Price 
 Per Share(1)           |       |    |     | Total               
 Number of Keystone  
 Purchase            
 Shares to be Issued |            |     | Percentage of 
 Outstanding   
 Common Stock  
 After Giving  
 Effect to the 
 Issuance      
 of Keystone   
 Purchase      
 Shares to     
 Keystone(2)   |      |   |     | Proceeds      
 from the Sale 
 of Keystone   
 Purchase      
 Shares